Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily Tiotropium in Asthma - PR Inside

15 They can continue to have symptoms and lifestyle restrictions and might even require emergency care. About Tiotropium Tiotropium (Spiriva®) is a long-acting inhaled anticholinergic medication and was the first inhaled maintenance treatment to provide ...

LABA/ICS Fixed-Dose Combinations Are the Most Commonly Prescribed Maintenance Therapies for Newly Diagnosed COPD Patients - Marketwatch

According to Treatment Algorithms in Chronic Obstructive Pulmonary Disease, Spiriva claims the highest patient share of COPD medications across all lines of therapy in newly diagnosed COPD patients. "Physicians likely prefer Spiriva because of ...

Do certain asthma inhalers increase risk of irregular heartbeat? - FOX News

Higher doses were associated with higher arrhythmia risk, while active users of a type of IAC called ipratropium (Atrovent) had a higher risk of arrhythmias than those who used tiotropium (Spiriva) or a combination of ipratropium and short-actin ...

Novartis lung drug superior to placebo over 1 year - msnbc.com

The drug also showed similar efficacy to open-label tiotropium or Spiriva from Pfizer and Boehringer Ingelheim, in patients with moderate-to-severe COPD. Novartis has carried out late-stage trials for NVA237, as it looks to tap into the ...

Asthma Meds May Be Linked to Irregular Heartbeat - US News and World Report

The type of anticholingeric drug used made a difference. No signficant risk was seen for tiotropium (Spiriva) or with ipratropium when it was combined with other asthma drugs called short-acting beta agonists, like albuterol. The increased risk ...

Boehringer Ingelheim’s once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD - PR Inside

4 It is being marketed under the brand name Spiriva ® in COPD. Spiriva ® HandiHaler ® is the most investigated and prescribed maintenance COPD drug worldwide. 25 Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim ...

BUYINS.NET: Market Maker Surveillance Report. PFE, NOK, INTC… - TMCnet

and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements ...

Phase 3 Trial Update of NVA237 for COPD - Monthly Prescribing Reference

Patients were randomized into three treatment arms receiving either once-daily NVA237 50mcg or placebo (double-blind), or once-daily OL tiotropium (Spiriva HandiHaler; Boehringer Ingelheim) 18mcg. They were also permitted to use COPD background therapy and ...

Asthma Prescription drugs Can be Linked to Unpredictable Heart cry - PR-USA.net

The type of anticholingeric substance used produced any variation. Absolutely no signficant possibility appeared to be noticed with regard to tiotropium (Spiriva) as well as by using ipratropium whenever it absolutely was in addition to additional asthma ...

NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update - Phramalive.com

In addition, NVA237 showed similar efficacy to OL tiotropium (Spiriva(R) HandiHaler(R)* Spiriva(R) HandiHaler(R) is a registered trademark by Boehringer Ingelheim Pharma Gmbh & Co. KG. /18 mcg) in patients with moderate-to-severe chronic ...